On May 5, 2025, Sophie Robert-Velut, previously Managing Director of dermo-cosmetics, rheumatology and dermatology activities, was appointed Managing Director of the Expanscience group by Jean-Paul Berthomé, who remains Chairman. This new governance structure is accompanied by a change in the composition of the Management Committee.
A B Corp-certified dermo-cosmetic and pharmaceutical laboratory and a company with a mission, Expanscience has set its sights high to become a regenerative company by 2040. Jean-Paul Berthomé has announced a change of governance to guarantee the company's sustainability and performance, both in financial and extra-financial terms, while preserving its fundamental values and family character.
From now on, the Executive Board will be led jointly by Jean-Paul Berthomé, who will continue to oversee the company's major strategic orientations as Chairman, and Sophie Robert-Velut, as Managing Director. Sophie Robert-Velut will be responsible for proposing and implementing Expanscience's strategy, with the support of the Management Committee, which she will lead.
"Founded by my father in 1950, this independent, family-run business has a major social role to play, reconciling utility with a contribution to the preservation of future generations. For over five years, Sophie Robert-Velut has been the driving force behind this ambitious strategic vision, a source of development and innovation. Her leadership, convictions and ability to mobilize teams have been decisive in helping our company grow responsibly. I would like to thank her for all she has achieved, and reiterate my full confidence in her new role. I know that with Sophie, the company will continue to extend its history and develop in line with our mission to help people shape their well-being.said Jean-Paul Berthomé.
"First of all, I would like to thank Jean-Paul Berthomé and the entire management committee for their confidence. I want Expanscience to be recognized as a pioneering company, capable of drawing other economic and political players into positive-impact business models. This mission goes hand in hand with the company's success, which depends on our ability to strengthen our financial health and prosperity in the dermo-cosmetics (Mustela and Babo Botanicals), rheumatology and well-being with age, and cosmetic and nutraceutical active ingredients markets. The commitment of our employees is key to this project".emphasized Sophie Robert-Velut.
New members on the Executive Committee
At the same time, the company's management committee welcomes three new members. Marguerite Laborde, Mustela Global Director, is an HEC graduate with a 20-year career in marketing and e-commerce in the cosmetics sector, working for companies such as l'Occitane and Cinq Mondes. With Expanscience since 2020, she has notably designed and managed the redesign of the Mustela brand and its offering in line with Expanscience's impACT roadmap, and strengthened support for parenthood in the group's subsidiaries. She was involved in the first convention of companies for the climate, and is now involved in the CEC Nouveaux Imaginaires.
Florence Pin, Global Healthcare Director, is a graduate of Paris Dauphine and IAE. She has over 25 years' experience in marketing and general management in the consumer goods and healthcare sectors within the Danone group. Since joining Expanscience in 2022, she has led the transformation of the Rheumatology business towards a long-term approach focused on well-being with age. In addition to managing the drug and medical device portfolio, she has coordinated the launch of the Iana brand and the Martha app: a new responsible and holistic health offering.
Konstandinos Katsianakos, General Manager of Markets, is a graduate of Reims Management School. He has over 25 years' experience in sales, marketing, business development and export in the pharmaceutical and cosmetics sector, most notably with Galderma. He joined Expanscience in 2012 and successively managed the international export business, then the international subsidiaries, before being appointed Managing Director of Markets in 2022. He has played a decisive role in accelerating Expanscience's international development through an offering strategy that is as close as possible to market specificities.
